Literature DB >> 26593489

Monoterpenes: Novel insights into their biological effects and roles on glucose uptake and lipid metabolism in 3T3-L1 adipocytes.

X C Tan1, K H Chua1, M Ravishankar Ram1, U R Kuppusamy2.   

Abstract

Various strategies have been adopted to combat complications caused by Type 2 diabetes mellitus and controlled diet is one of them. Monoterpenes, major constituents of essential oils, are synthesized and widely used as artificial food flavors. A series of twelve monoterpenes were assessed in the present study. Monoterpenes, exhibited low 2,2-diphenyl-2-picrylhydrazyl hydrate (DPPH) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity even at high concentrations. Some monoterpenes inhibited α-amylase and α-glucosidase activity and stimulated glucose uptake and lipolysis. Monoterpenes such as (R)-(+)-limonene stimulated both glucose uptake (17.4%) and lipolysis (17.7%); the mRNA expression of glucose transporter 1 (GLUT1) was upregulated but glucose transporter 4 (GLUT4) was unaffected, and adipose triglyceride lipase (ATGL) was suppressed. Taken together, the selected monoterpenes may not confer strong protection against free radicals but nevertheless, their positive influence on lipid and glucose metabolism may have potential in the control of obesity and Type 2 diabetes mellitus.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant; Glucose uptake; Lipolysis; Monoterpene; α-Amylase; α-Glucosidase

Mesh:

Substances:

Year:  2015        PMID: 26593489     DOI: 10.1016/j.foodchem.2015.09.042

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  8 in total

1.  Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.

Authors:  Rohit Sinha; Khalida A Lockman; Natalie Z M Homer; Edward Bower; Paul Brinkman; Hugo H Knobel; Jonathan A Fallowfield; Alan J Jaap; Peter C Hayes; John N Plevris
Journal:  JHEP Rep       Date:  2020-06-15

2.  Miconia sp. Increases mRNA Levels of PPAR Gamma and Inhibits Alpha Amylase and Alpha Glucosidase.

Authors:  David Mizael Ortíz-Martinez; Catalina Rivas-Morales; Myriam Angelica de la Garza-Ramos; Maria Julia Verde-Star; Maria Adriana Nuñez-Gonzalez; Catalina Leos-Rivas
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-13       Impact factor: 2.629

Review 3.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

4.  Effects of Essential Oils and Some Constituents from Ingredients of Anti-Cellulite Herbal Compress on 3T3-L1 Adipocytes and Rat Aortae.

Authors:  Ngamrayu Ngamdokmai; Tamkeen Urooj Paracha; Neti Waranuch; Krongkarn Chootip; Wudtichai Wisuitiprot; Nungruthai Suphrom; Kamonlak Insumrong; Kornkanok Ingkaninan
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-11

Review 5.  In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update.

Authors:  Lina T Al Kury; Aya Abdoh; Kamel Ikbariah; Bassem Sadek; Mohamed Mahgoub
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

6.  Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs.

Authors:  Anna Drzazga; Daria Kamińska; Anna Gliszczyńska; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

7.  The Antibacterial Activity of Chitosan Products Blended with Monoterpenes and Their Biofilms against Plant Pathogenic Bacteria.

Authors:  Mohamed E I Badawy; Entsar I Rabea; Nehad E M Taktak; Mahmoud A M El-Nouby
Journal:  Scientifica (Cairo)       Date:  2016-04-04

8.  R-Limonene Enhances Differentiation and 2-Deoxy-D-Glucose Uptake in 3T3-L1 Preadipocytes by Activating the Akt Signaling Pathway.

Authors:  Ilavenil Soundharrajan; Da Hye Kim; Srigopalram Srisesharam; Palaniselvem Kuppusamy; Ki Choon Choi
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-03       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.